| Date Filed | Type | Description |
| 04/01/2013 |
8-K
| Bankruptcy or Receivership, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation unde... |
| 03/21/2013 |
8-K
| Quarterly results |
| 03/18/2013 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 03/15/2013 |
8-K
| Material Modifications to Rights of Security Holders, Submission of Matters to a Vote of Security Holders, Financial Statemen... |
| 03/07/2013 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/07/2013 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 03/07/2013 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 03/05/2013 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 02/21/2013 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements |
| 02/14/2013 |
SC 13G/A
| FMR LLC reports a 8.4% stake in POLYMEDIX INC |
| 01/23/2013 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits |
| 11/20/2012 |
SC 13D/A
| Target Capital Management reports a 6.9% stake in POLYMEDIX, INC. |
| 11/09/2012 |
10-Q
| Quarterly Report for the period ended September 30, 2012 |
| 11/09/2012 |
8-K
| Quarterly results |
| 08/09/2012 |
10-Q
| Quarterly Report for the period ended June 30, 2012 |
| 08/09/2012 |
8-K
| Quarterly results |
| 06/12/2012 |
8-K
| Form 8-K - Current report |
| 05/10/2012 |
10-Q
| Quarterly Report for the period ended May 9, 2012 |
| 05/04/2012 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 04/23/2012 |
8-K
| Investor presentation |
| 04/10/2012 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"Loan and Security Agreement by and among PolyMedix, Inc., PolyMedix Pharmaceuticals, Inc., MidCap Financial SBIC, LP, as administrative agent, and the lenders listed thereto from time to time",
"Warrant to Purchase Common Stock",
"Registration Rights Agreement by and between PolyMedix, Inc. and MidCap Financial SBIC, LP",
"PolyMedix Restructures its Debt and Secures $12 Million Credit Facility" |
|
| 04/10/2012 |
8-K
| Form 8-K - Current report |
| 03/28/2012 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 03/28/2012 |
4
| Swirsky Douglas J (Director) has filed a Form 4 on POLYMEDIX, INC |
| 03/28/2012 |
4
| Loren Stefan (Director) has filed a Form 4 on POLYMEDIX, INC |
| 03/28/2012 |
4
| Lewis Michael E (Director) has filed a Form 4 on POLYMEDIX, INC|
Txns:
| Granted 37,000 options to buy
@ $1.22, valued at
$45.1k
|
|
| 03/28/2012 |
4
| BANK RICHARD W (Director) has filed a Form 4 on POLYMEDIX, INC|
Txns:
| Granted 37,000 options to buy
@ $1.22, valued at
$45.1k
|
|
| 03/28/2012 |
4
| ANDERSON BRIAN (Director) has filed a Form 4 on POLYMEDIX, INC|
Txns:
| Granted 37,000 options to buy
@ $1.22, valued at
$45.1k
|
|
| 03/28/2012 |
SC 13D/A
| Landekic Nicholas reports a 5.6% stake in PolyMedix, Inc. |
| 03/28/2012 |
4
| Scott Richard W (VP Research) has filed a Form 4 on POLYMEDIX, INC |
| 03/28/2012 |
4
| Smith Edward F (CFO) has filed a Form 4 on POLYMEDIX, INC |
| 03/28/2012 |
4
| Korczak Bozena (VP Drug Development) has filed a Form 4 on POLYMEDIX, INC |
| 03/28/2012 |
4
| JORGENSEN DANIEL (Sr VP Clinical Dev & CMO) has filed a Form 4 on POLYMEDIX, INC |
| 03/28/2012 |
4
| Landekic Nicholas (CEO) has filed a Form 4 on POLYMEDIX, INC |
|